Northern Trust Corp Bellerophon Therapeutics, Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.76 $3,028 - $6,057	-7,970 Reduced 20.85%	30,251 $12,000
Q2 2023 Aug 11, 2023	BUY	$0.68 - $12.39 $5,498 - $100,185	8,086 Added 26.83%	38,221 $26,000
Q1 2023 May 15, 2023	BUY	$0.9 - $7.89 $1,834 - $16,079	2,038 Added 7.25%	30,135 $237,000
Q1 2022 May 13, 2022	SELL	$1.82 - $3.24 $15,129 - $26,934	-8,313 Reduced 22.83%	28,097 $66,000
Q4 2021 Feb 08, 2022	SELL	$2.36 - $4.05 $573 - $984	-243 Reduced 0.66%	36,410 $113,000

Q3 2021 Nov 15, 2021	BUY	$3.75 - $4.86 $367 - $476	98 Added 0.27%	36,653 $149,000
Q2 2021 Aug 13, 2021	SELL	$3.83 - $5.65 $149,461 - $220,485	-39,024 Reduced 51.63%	36,555 $177,000
Q1 2021 May 12, 2021	SELL	$5.07 - $8.27 $71,121 - $116,011	-14,028 Reduced 15.66%	75,579 $393,000
Q4 2020 Feb 11, 2021	SELL	$6.12 - $10.37 $16,028 - $27,159	-2,619 Reduced 2.84%	89,607 $598,000
Q3 2020 Nov 16, 2020	BUY	$9.27 - $13.79 $19,847 - $29,524	2,141 Added 2.38%	92,226 $938,000
Q2 2020 Aug 14, 2020	BUY	$9.43 - $20.28 $849,501 - $1.83 Million	90,085 New	90,085 $1.13 Million

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $477K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.